Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

352 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Targeting CXCR4 (CXC Chemokine Receptor Type 4) for Molecular Imaging of Aldosterone-Producing Adenoma.
Heinze B, Fuss CT, Mulatero P, Beuschlein F, Reincke M, Mustafa M, Schirbel A, Deutschbein T, Williams TA, Rhayem Y, Quinkler M, Rayes N, Monticone S, Wild V, Gomez-Sanchez CE, Reis AC, Petersenn S, Wester HJ, Kropf S, Fassnacht M, Lang K, Herrmann K, Buck AK, Bluemel C, Hahner S. Heinze B, et al. Among authors: buck ak. Hypertension. 2018 Feb;71(2):317-325. doi: 10.1161/HYPERTENSIONAHA.117.09975. Epub 2017 Dec 26. Hypertension. 2018. PMID: 29279316 Free article.
Molecular imaging of proliferation in malignant lymphoma.
Buck AK, Bommer M, Stilgenbauer S, Juweid M, Glatting G, Schirrmeister H, Mattfeldt T, Tepsic D, Bunjes D, Mottaghy FM, Krause BJ, Neumaier B, Döhner H, Möller P, Reske SN. Buck AK, et al. Cancer Res. 2006 Nov 15;66(22):11055-61. doi: 10.1158/0008-5472.CAN-06-1955. Cancer Res. 2006. PMID: 17108145
Performance of integrated FDG-PET/CT for differentiating benign and malignant lung lesions--results from a large prospective clinical trial.
Pauls S, Buck AK, Halter G, Mottaghy FM, Muche R, Bluemel C, Gerstner S, Krüger S, Glatting G, Sunder-Plassmann L, Möller P, Brambs HJ, Reske SN. Pauls S, et al. Among authors: buck ak. Mol Imaging Biol. 2008 Mar-Apr;10(2):121-8. doi: 10.1007/s11307-007-0129-9. Epub 2008 Jan 16. Mol Imaging Biol. 2008. PMID: 18204955 Clinical Trial.
Early metabolic response evaluation by fluorine-18 fluorodeoxyglucose positron emission tomography allows in vivo testing of chemosensitivity in gastric cancer: long-term results of a prospective study.
Ott K, Herrmann K, Lordick F, Wieder H, Weber WA, Becker K, Buck AK, Dobritz M, Fink U, Ulm K, Schuster T, Schwaiger M, Siewert JR, Krause BJ. Ott K, et al. Among authors: buck ak. Clin Cancer Res. 2008 Apr 1;14(7):2012-8. doi: 10.1158/1078-0432.CCR-07-0934. Clin Cancer Res. 2008. PMID: 18381939
Imaging bone and soft tissue tumors with the proliferation marker [18F]fluorodeoxythymidine.
Buck AK, Herrmann K, Büschenfelde CM, Juweid ME, Bischoff M, Glatting G, Weirich G, Möller P, Wester HJ, Scheidhauer K, Dechow T, Peschel C, Schwaiger M, Reske SN. Buck AK, et al. Clin Cancer Res. 2008 May 15;14(10):2970-7. doi: 10.1158/1078-0432.CCR-07-4294. Epub 2008 Apr 29. Clin Cancer Res. 2008. PMID: 18445694 Clinical Trial.
SPECT/CT.
Buck AK, Nekolla S, Ziegler S, Beer A, Krause BJ, Herrmann K, Scheidhauer K, Wester HJ, Rummeny EJ, Schwaiger M, Drzezga A. Buck AK, et al. J Nucl Med. 2008 Aug;49(8):1305-19. doi: 10.2967/jnumed.107.050195. Epub 2008 Jul 16. J Nucl Med. 2008. PMID: 18632825 Free article.
Imaging proliferation to monitor early response of lymphoma to cytotoxic treatment.
Graf N, Herrmann K, den Hollander J, Fend F, Schuster T, Wester HJ, Senekowitsch-Schmidtke R, zum Büschenfelde CM, Peschel C, Schwaiger M, Dechow T, Buck AK. Graf N, et al. Among authors: buck ak. Mol Imaging Biol. 2008 Nov-Dec;10(6):349-55. doi: 10.1007/s11307-008-0162-3. Epub 2008 Aug 14. Mol Imaging Biol. 2008. PMID: 18704591
352 results